Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED).

Clinical trial NCT07264517 · COMPLETED

Trial details

NCT number: NCT07264517
Sponsor: Instituto Grifols, S.A.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Dry Eye Disease

Start date: 2025-11-03
Primary completion: 2026-05-20
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.